RhemaStem
Pre-clinicalRhemaStem’s mission is to identify and develop therapeutic targets to cure colorectal and other solid cancers in the area of cancer and normal stem cells.
Founded
2016
Focus
Cell & Gene Therapy
About
RhemaStem’s mission is to identify and develop therapeutic targets to cure colorectal and other solid cancers in the area of cancer and normal stem cells.
Funding History
2Total raised: $12.5M
Series A$10MPanakes PartnersMar 15, 2023
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationMilan, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile